The First Discovery of a Single Digit Nanomolar Small Molecule Blocker of a Protein-protein Interaction Target

Video   Jul 03, 2015

 



About the Speaker
Dr. Nils Hansen is the CEO and founder of Vipergen ApS. He is the principal inventor of the enabling YoctoReactor® and Binder Trap Enrichment® drug discovery technology platforms. He previously worked for Praecis Pharmaceuticals Inc., (Waltham, MA, USA) and Symphogen A/S, (Copenhagen, Denmark). Dr. Hansen earned his Ph.D. in immunology from the University of Copenhagen, Denmark in 2000 and his M.Sc. in Chemistry and Biotechnology from the University of Aarhus, Denmark in 1996.Abstract
Effective small molecule PPI blocker discovery using high fidelity DNA-encoded libraries and a low-noise homogeneous screening assay. The screen employs a unique principle of trapping small molecule binders together with the protein target in miniscule droplets.

 
 
 
 

Recommended Videos

New Pressure Controller Solution: LineUP™ Series

Video

Fluigent LineUP™ Series is a complete solution for using air pressure to drive fluid flow with the highest flexibility and ease of use.

WATCH NOW

Why Do Coffee Naps Recharge You So Well?

Video

With their powers combined, coffee and naps create a greater sum than their parts.

WATCH NOW

The Deadliest Being on Planet Earth – The Bacteriophage

Video

A war has been raging for billions of years, killing trillions every single day, while we don’t even notice. This war involves the single deadliest being on our planet: The Bacteriophage.

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy